Gelder Mark S. Md - Net Worth and Insider Trading
Gelder Mark S. Md Net Worth
The estimated net worth of Gelder Mark S. Md is at least $560 dollars as of 2024-11-13. Gelder Mark S. Md is the Chief Medical Officer of Traws Pharma Inc and owns about 95 shares of Traws Pharma Inc (TRAW) stock worth over $560. Details can be seen in Gelder Mark S. Md's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Gelder Mark S. Md has not made any transactions after 2021-09-28 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Gelder Mark S. Md
Gelder Mark S. Md Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Gelder Mark S. Md owns 2 companies in total, including Heron Therapeutics Inc (HRTX) , and Traws Pharma Inc (TRAW) .
Click here to see the complete history of Gelder Mark S. Md’s form 4 insider trades.
Insider Ownership Summary of Gelder Mark S. Md
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| HRTX | Heron Therapeutics Inc | 2012-12-03 | SVP & Chief Medical Officer |
| TRAW | Traws Pharma Inc | 2021-09-28 | Chief Medical Officer |
Gelder Mark S. Md Latest Holdings Summary
Gelder Mark S. Md currently owns a total of 1 stock. Gelder Mark S. Md owns 95 shares of Traws Pharma Inc (TRAW) as of September 28, 2021, with a value of $560.
Latest Holdings of Gelder Mark S. Md
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| TRAW | Traws Pharma Inc | 2021-09-28 | 95 | 5.90 | 560 |
Holding Weightings of Gelder Mark S. Md
Gelder Mark S. Md Form 4 Trading Tracker
According to the SEC Form 4 filings, Gelder Mark S. Md has made a total of 1 transactions in Traws Pharma Inc (TRAW) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Traws Pharma Inc is the acquisition of 95 shares on September 28, 2021, which cost Gelder Mark S. Md around $10,000.
Insider Trading History of Gelder Mark S. Md
- 1
Gelder Mark S. Md Trading Performance
GuruFocus tracks the stock performance after each of Gelder Mark S. Md's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Gelder Mark S. Md is -33.6%. GuruFocus also compares Gelder Mark S. Md's trading performance to market benchmark return within the same time period. The performance of stocks bought by Gelder Mark S. Md within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Gelder Mark S. Md's insider trading performs compared to the benchmark.
Performance of Gelder Mark S. Md
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -8.66 | | | | | |
| Relative Return to S&P 500(%) | -14.26 | | | | | |
Gelder Mark S. Md Ownership Network
Ownership Network List of Gelder Mark S. Md
Ownership Network Relation of Gelder Mark S. Md
Gelder Mark S. Md Owned Company Details
What does Heron Therapeutics Inc do?
Who are the key executives at Heron Therapeutics Inc?
Gelder Mark S. Md is the SVP & Chief Medical Officer of Heron Therapeutics Inc. Other key executives at Heron Therapeutics Inc include EVP & Chief Development Officer William P Forbes , other: See Footnote 2 Adam Morgan , and EVP & Chief Financial Officer Ira Duarte .
Heron Therapeutics Inc (HRTX) Insider Trades Summary
Over the past 18 months, Gelder Mark S. Md made no insider transaction in Heron Therapeutics Inc (HRTX). Other recent insider transactions involving Heron Therapeutics Inc (HRTX) include a net purchase of 2,486,744 shares made by Adam Morgan , and a net purchase of 50,000 shares made by William P Forbes .
In summary, during the past 3 months, insiders sold 0 shares of Heron Therapeutics Inc (HRTX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Heron Therapeutics Inc (HRTX) were sold and 2,536,744 shares were bought by its insiders, resulting in a net purchase of 2,536,744 shares.
Heron Therapeutics Inc (HRTX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Heron Therapeutics Inc Insider Transactions
Gelder Mark S. Md Mailing Address
Above is the net worth, insider trading, and ownership report for Gelder Mark S. Md. You might contact Gelder Mark S. Md via mailing address: C/o A.p. Pharma, Inc., 123 Saginaw Drive, Redwood City Ca 94063.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
